{"symbol": "ZFGN", "companyName": "Zafgen Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.zafgen.com", "description": "Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.", "CEO": "Jeffrey S. Hatfield", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}